---
title: "Viyash Scientific Ltd (VIYASH) — Share Price, Financials & Analysis"
symbol: "VIYASH"
company: "Viyash Scientific Ltd"
canonical: "https://tapetide.com/stocks/VIYASH"
isin: "INE807F01027"
nse_symbol: "VIYASH"
bse_code: "512529"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 11159.98
generated_at: "2026-09-13T19:21:19.950Z"
---

# Viyash Scientific Ltd (VIYASH)

Canonical page: https://tapetide.com/stocks/VIYASH

## Company

- **NSE Symbol:** VIYASH
- **BSE Code:** 512529
- **ISIN:** INE807F01027
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2016-03-10
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** sequent.in

## About

Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.

## Latest Price

- **Price:** ₹257.6
- **Change:** -2.85 (-1.09%)
- **Open:** ₹259.3
- **Day High:** ₹259.35
- **Day Low:** ₹253.5
- **Previous Close:** ₹260.45
- **Volume:** 1859725
- **As Of:** 2026-09-11T10:28:15+00:00

## Key Fundamentals

Observed at 2026-09-11T04:46:34.841233Z.

- **Market Cap:** ₹11159.98 Cr
- **Classification:** Microcap
- **P/E (reported):** 43
- **P/E (TTM):** 44.72
- **EPS (TTM):** ₹5.76
- **Book Value:** ₹64
- **Price to Book:** 4.08
- **Dividend Yield:** 0.19%
- **ROE:** 7.21%
- **ROCE:** 11.36%
- **Debt to Equity:** 0.17
- **Revenue (yearly):** ₹3463.9 Cr
- **Net Income:** ₹224.7 Cr
- **EBITDA:** ₹696.1 Cr
- **52-Week High:** ₹298
- **52-Week Low:** ₹178.13
- **RSI (14):** 46.88

## Tapetide Score

- **Score:** 52 / 100
- **Score date:** 2026-09-04
- **Archetype:** No Dominant Pattern
- **What it means:** The three pillars do not combine into a recognisable pattern. Read them individually rather than looking for one story — the lack of a pattern is itself the finding.
- **Pillar profile:** Quality: Weak · Valuation: Fair · Momentum: Flat
- **Percentile:** 56.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 39.89 | 9% |
| growth | 97.57 | 9% |
| momentum | 59.61 | 12% |
| ownership | 49.93 | 24% |
| quality | 38.48 | 22% |
| valuation | 53.97 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is expected to give good quarter

### Weaknesses

- Stock is trading at 3.87 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 3.80% over last 3 years.
- Working capital days have increased from 71.6 days to 111 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -6.35% | 955.26% | 955.26% |
| ebitda margin growth | -6.74% | 45.55% | 283.59% | 137.87% |
| net income growth | 19.43% | — | 73% | 15% |
| revenue growth | 2.01% | 13.96% | 34% | 20% |
| roce | -10.62% | 256.11% | — | 2.12% |
| roe | 19.45% | — | 1.22% | 19.17% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 346 | 329 | 361 | 390 | 369 | 774 | 402 | 792 | 850 | 858 | 920 | 946 |
| Expenses | 331 | 307 | 329 | 348 | 330 | 674 | 355 | 673 | 677 | 683 | 736 | 768 |
| Operating Profit | 15 | 22 | 32 | 42 | 39 | 100 | 46 | 119 | 173 | 176 | 184 | 178 |
| OPM % | 4.4 | 7 | 9 | 11 | 11 | 13 | 12 | 15 | 20 | 20 | 20 | 19 |
| Other Income | 10 | 7 | -1 | 3 | 0 | 4 | 1 | 6 | 6 | -27 | 16 | 8 |
| Interest | 13 | 13 | 12 | 16 | 14 | 21 | 15 | 20 | 18 | 17 | 15 | 13 |
| Depreciation | 15 | 15 | 16 | 16 | 17 | 58 | 16 | 56 | 59 | 59 | 60 | 62 |
| Profit before tax | -3 | 1 | 3 | 12 | 8 | 24 | 16 | 48 | 102 | 73 | 125 | 112 |
| Tax % | 123 | -617 | 52 | 24 | 20 | -71 | 36 | 24 | 29 | 34 | 47 | 29 |
| Net Profit | -7 | 11 | 1 | 9 | 6 | 42 | 10 | 37 | 73 | 49 | 66 | 79 |
| EPS in Rs | -0.34 | 0.33 | -0.04 | 0.26 | 0.1 | 1.78 | 0.37 | 1.27 | 2.18 | 0.88 | 1.19 | 1.51 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 848 | 1039 | 1179 | 1362 | 1413 | 1421 | 1370 | 3007 | 3420 | 3575 |
| Expenses | 765 | 914 | 1009 | 1150 | 1303 | 1409 | 1308 | 2620 | 2768 | 2864 |
| Operating Profit | 83 | 125 | 170 | 212 | 109 | 12 | 61 | 387 | 653 | 711 |
| OPM % | 10 | 12 | 14 | 16 | 8 | 0.8 | 4.5 | 13 | 19 | 20 |
| Other Income | 436 | 9 | 10 | 0 | 11 | -58 | -6 | -49 | -1 | 3 |
| Interest | 33 | 33 | 36 | 24 | 16 | 36 | 48 | 86 | 69 | 61 |
| Depreciation | 41 | 42 | 51 | 51 | 52 | 56 | 62 | 239 | 234 | 240 |
| Profit before tax | 444 | 59 | 94 | 137 | 53 | -138 | -55 | 13 | 349 | 413 |
| Tax % | 3 | 3 | 13 | 24 | 15 | -11 | -46 | -20 | 36 | — |
| Net Profit | 431 | 57 | 82 | 104 | 45 | -122 | -30 | 16 | 225 | 267 |
| EPS in Rs | 17.3 | 1.97 | 2.81 | 3.84 | 1.65 | -4.86 | -1.44 | 0.93 | 4.06 | 5.76 |
| Dividend Payout % | 1 | 10 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 49 | 49 | 49 | 50 | 50 | 50 | 50 | 50 | 50 | 87 |
| Reserves | 928 | 599 | 657 | 637 | 678 | 642 | 649 | 607 | 2382 | 2824 |
| Borrowings | 416 | 305 | 325 | 343 | 277 | 365 | 444 | 488 | 654 | 490 |
| Other Liabilities | 503 | 380 | 346 | 424 | 381 | 378 | 374 | 389 | 1042 | 1195 |
| Total Liabilities | 1896 | 1332 | 1378 | 1454 | 1386 | 1435 | 1517 | 1534 | 4128 | 4596 |
| Fixed Assets | 684 | 476 | 498 | 577 | 536 | 564 | 605 | 592 | 2103 | 2103 |
| CWIP | 33 | 18 | 23 | 13 | 31 | 12 | 55 | 16 | 43 | 70 |
| Investments | 428 | 239 | 180 | 171 | 83 | 38 | 0 | 4 | 0 | 0 |
| Other Assets | 751 | 599 | 677 | 693 | 737 | 821 | 856 | 922 | 1981 | 2422 |
| Total Assets | 1896 | 1332 | 1378 | 1454 | 1386 | 1435 | 1517 | 1534 | 4128 | 4596 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -7 | 45 | 116 | 115 | 115 | 31 | 17 | 31 | 345 | 323 |
| Cash from Investing Activity | -116 | 7 | -68 | -72 | 10 | -94 | -65 | -6 | -448 | -84 |
| Cash from Financing Activity | 147 | -57 | -20 | -43 | -139 | 67 | 32 | -1 | 87 | -123 |
| Net Cash Flow | 24 | -5 | 28 | 0 | -14 | 4 | -16 | 23 | -16 | 115 |
| Free Cash Flow | -82 | 0 | 92 | 75 | 70 | -1 | -58 | 19 | 258 | 225 |
| CFO/OP | 5 | 65 | 92 | 75 | 75 | 52 | 263 | 73 | 102 | 59 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 136 | 111 | 98 | 99 | 93 | 85 | 88 | 89 | 98 | 112 |
| Inventory Days | 165 | 125 | 134 | 132 | 139 | 160 | 152 | 166 | 169 | 188 |
| Days Payable | 208 | 127 | 141 | 133 | 119 | 119 | 107 | 121 | 121 | 140 |
| Cash Conversion Cycle | 93 | 110 | 92 | 98 | 112 | 126 | 132 | 135 | 146 | 160 |
| Working Capital Days | -25 | 20 | 33 | 29 | 51 | 54 | 46 | 30 | 74 | 111 |
| ROCE % | 1 | 40 | 9 | 12 | 16 | 6 | -3 | 0 | 8 | 13 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 52.79% | 52.79% | 52.79% | 52.78% | 52.76% | 52.61% | 52.61% | 52.61% | 52.33% | 61.41% | 61.31% | 61.31% |
| FIIs | 6.03% | 6.12% | 6.16% | 5.7% | 6.45% | 6.1% | 6.05% | 6.15% | 5.91% | 3.16% | 2.94% | 4.5% |
| DIIs | 3.23% | 5.02% | 7.59% | 8.06% | 9.99% | 12.02% | 12.82% | 12.98% | 12.91% | 7.36% | 7.99% | 3.75% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 29.25% | 25.11% | 24.43% | 25.01% | 24% | 23.82% | 23.43% | 22.37% | 22.72% | 19.24% | 18.97% | 20.52% |
| Others | 8.7% | 10.96% | 9.02% | 8.45% | 6.8% | 5.46% | 5.09% | 5.89% | 6.13% | 8.82% | 8.79% | 9.91% |
| No. of Shareholders | 184521 | 172853 | 166593 | 163693 | 154603 | 162574 | 158152 | 147320 | 144085 | 135389 | 127446 | 128367 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 7 / 4 / 8

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 261.69 | Sell |
| EMA (10) | 261.81 | Sell |
| SMA (20) | 263.95 | Sell |
| EMA (20) | 263.13 | Sell |
| SMA (50) | 266.09 | Sell |
| EMA (50) | 262.19 | Sell |
| SMA (100) | 254.43 | Buy |
| EMA (100) | 253 | Buy |
| SMA (200) | 230.07 | Buy |
| EMA (200) | 234.86 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 44.63 | Neutral |
| MACD (12,26,9) | -1.31 | Sell |
| Stochastic (14,3,3) | 19.82 | Buy |
| ADX (14) | 10.99 | Neutral |
| Williams %R (14) | -84.53 | Buy |
| ATR (14) | 8.8 | High Volatility |
| ROC (12) | -2.2 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 52.85 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 3 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 3 analyst ratings, observed at 2026-09-11T04:46:34.828863+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Update On Proposed Acquisition Of Bioforlife Italia S.R.L](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c33c6752-e581-4dc7-91b9-13a44fe2675b.pdf) |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb16aa46-4a31-4d00-8e18-cb874f43a6d2.pdf) |
| 2026-08-27 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=F7218042_3FA1_4701_861D_0CAA7CA0DA6D_142501.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=402b5e10-d36c-4574-8314-4e0b4943eeb9.pdf) |
| 2026-08-11 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94017f1e-cce9-4422-acf0-1ea9462773c1.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d1b1183-613d-4722-81ef-734cb8ea5e3c.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5897692-f418-41b6-b827-a5a8e176b3a4.pdf) |
| 2026-08-11 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=771fd0c3-b79b-4cf3-a9df-eaa021ed38d9.pdf) |
| 2026-08-11 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bac53639-194f-4d71-9a87-2ab2a6f7e330.pdf) |
| 2026-08-11 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d6009b8-613a-4f7e-a898-8d805e916045.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-16 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63a27d61-a483-4b08-a88e-aa964364a0c8.pdf) |
| 2026-05-22 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba96e5c0-0724-4b7c-869d-e5b9e81f1adf.pdf) |
| 2026-02-09 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=785902df-3c4d-47d2-a4ae-a2f88f8a2207.pdf) |
| 2025-11-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2273155-21a3-4560-9465-b3ce9ec2c8f6.pdf) |
| 2025-08-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c311c218-9013-4c3a-91d1-2c26d7e9e05e.pdf) |
| 2025-08-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0f8d68f-917e-4559-85e9-2ae114b069b7.pdf) |
| 2025-05-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=336e79a5-abde-4aaa-b9a9-d1f5bee5a34a.pdf) |
| 2024-11-22 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50d7272f-14a2-47ef-af9a-83a1313712b2.pdf) |
| 2024-08-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04a0ba13-aa94-4d48-b430-2ff04e0fe95a.pdf) |
| 2024-05-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59bf31de-a479-472d-9334-2af03f5ae344.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7aa4d7a1-283b-40f1-ac9c-bec291174214.pdf) |
| 2026-06-11 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05b873bd-66fa-4082-9b0e-7c0afe87de2c.pdf) |
| 2026-05-20 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb94c082-0b5d-40c8-931b-cf30fb654419.pdf) |
| 2026-02-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93b8eed5-9a7e-4ad4-a637-3524baa50431.pdf) |
| 2025-08-11 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf369d20-39f4-4723-984f-8d6debfbe5c0.pdf) |
| 2024-11-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fd213ec-096b-45e0-bc8f-f9b788053526.pdf) |
| 2024-10-02 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22cdf673-da7a-4add-a771-655eafcc8528.pdf) |
| 2024-06-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76f60cb1-9e4d-4f38-9206-0bffab1e47d5.pdf) |
| 2024-02-15 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3452d4bb-eff1-4e2f-9f6b-d443cc195c66.pdf) |
| 2023-11-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a89a3d7-19d9-44e5-a823-0c2eb5145746.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24c9c8ae-50fd-4b39-8752-ebf166a14c42.pdf) |
| 2026-06-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d77c1451-a64a-49cd-844c-b5d087b3cb56.pdf) |
| 2026-05-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44f1a1ac-18e6-4b29-af83-69b6569bfba5.pdf) |
| 2026-02-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa67a964-c0c4-457c-9c54-532ec458ca4b.pdf) |
| 2025-11-18 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31845c8a-1041-421f-b5e9-9cca1abdc372.pdf) |
| 2025-11-17 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=faecb00c-1f79-4dd2-a81d-d3fb6336fbae.pdf) |
| 2025-05-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58080066-33d3-49be-8c38-e66df62f1330.pdf) |
| 2025-02-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bae82f92-33a6-4aff-9153-0c42d50475b7.pdf) |
| 2024-11-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee234a00-3da8-4005-9bc5-7334d8f50e50.pdf) |
| 2024-09-27 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80c11943-5d3a-4825-8d4f-8890523b5194.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-11 | [Unaudited Financial Results For Q1 FY 2026-2027](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7301878-41dd-4a8f-abb0-f2afd64fd090.pdf) |
| 2026-05-19 | [Results For The Quarter And Year Ended 31 March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a3f9e1f-8902-4e9e-8c1d-5fdbee2b64bb.pdf) |
| 2026-02-05 | [Unaudited Standalone & Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28849810-27e1-49f6-a3fa-c13416fe20e3.pdf) |
| 2025-11-14 | [Q2 FY26 Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ee5b962-937b-499e-992e-f5c5da480312.pdf) |
| 2025-08-08 | [Unaudited Standalone & Consolidated Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3b4b59d-2d23-4dd4-a169-ab80c3de937f.pdf) |
| 2025-05-20 | [Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fa066d0-3040-4022-88c5-4760985bc9cf.pdf) |
| 2025-02-11 | [Outcome Of Board Meeting Held On February 11 2025 Along With Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2b45a0c-9c7a-4e11-b594-e021c9f0e5d7.pdf) |
| 2024-11-13 | [Q2FY25 Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d5b604b-4f25-4cde-b9e7-2480c3a021b0.pdf) |
| 2024-08-14 | [Sequent Results Q1 FY2024-25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2a1e4b5-b86d-44da-95d8-749b0d1b86f5.pdf) |
| 2024-05-15 | [Outcome Of Board Meeting Held On May 15, 2024 Along With Audited Standalone &<BR> Consolidated Financial Results For The Quarter And Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d2b46a0-d546-4a6d-8550-4dfeef968f62.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a401f74-5f73-46a4-9157-17d46401a51e.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3a401f74-5f73-46a4-9157-17d46401a51e.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=243d9f71-742f-47a4-8a61-3a7831b082b3.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/faecb00c-1f79-4dd2-a81d-d3fb6336fbae.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/243d9f71-742f-47a4-8a61-3a7831b082b3.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c2273155-21a3-4560-9465-b3ce9ec2c8f6.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/50d7272f-14a2-47ef-af9a-83a1313712b2.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/eac90fd1-16a8-41ae-8335-9286207f2749.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ba96e5c0-0724-4b7c-869d-e5b9e81f1adf.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ba96e5c0-0724-4b7c-869d-e5b9e81f1adf.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 5h - ICRA assigned [ICRA]AA- Stable rating to Viyash Scientific’s Rs185 crore working capital facilities. | [Announcement under Regulation 30 (LODR)-Credit Rating 5h - ICRA assigned [ICRA]AA- Stable rating to Viyash Scientific’s Rs185 crore working capital facilities.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/413f9e33-c306-4fae-90c4-262345b6403a.pdf) |
| 31 Mar - Clarifies previous intimation: Dr. Fabian Kausche and Gregory Andrews resigned effective March 30, 2026. | [Clarification Letter 31 Mar - Clarifies previous intimation: Dr. Fabian Kausche and Gregory Andrews resigned effective March 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2251f037-2964-4578-a758-228fd92e1182.pdf) |
| 30 Mar - Dr Fabian Kausche and Mr Gregory Andrews resign as non-exec directors effective March 30, 2026. | [Announcement under Regulation 30 (LODR)-Resignation of Director 30 Mar - Dr Fabian Kausche and Mr Gregory Andrews resign as non-exec directors effective March 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8617749f-5773-42e5-b481-a9986c6db286.pdf) |
| 30 Apr - India Ratings upgraded Viyash’s INR 350 million bank facilities to IND AA-/Stable and IND A1+. | [Announcement under Regulation 30 (LODR)-Credit Rating 30 Apr - India Ratings upgraded Viyash’s INR 350 million bank facilities to IND AA-/Stable and IND A1+.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1df035e7-4bdf-4874-a620-c92f3e0d203e.pdf) |
| 30 Apr - India Ratings upgraded Viyash’s INR 350 million bank facilities to IND AA-/Stable and IND A1+. | [Announcement under Regulation 30 (LODR)-Credit Rating 30 Apr - India Ratings upgraded Viyash’s INR 350 million bank facilities to IND AA-/Stable and IND A1+.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1df035e7-4bdf-4874-a620-c92f3e0d203e.pdf) |
| 22 Apr - ICRA assigned [ICRA]AA- Stable rating to Viyash Scientific’s Rs185 crore working capital facilities. | [Announcement under Regulation 30 (LODR)-Credit Rating 22 Apr - ICRA assigned [ICRA]AA- Stable rating to Viyash Scientific’s Rs185 crore working capital facilities.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/413f9e33-c306-4fae-90c4-262345b6403a.pdf) |
| 22 Apr - Board appointed Amit Jain and Abhiroop Jayanthi as directors, and revised ESOP pool to 1,30,98,000 options. | [Board Meeting Outcome for Outcome Of Board Meeting 22 Apr - Board appointed Amit Jain and Abhiroop Jayanthi as directors, and revised ESOP pool to 1,30,98,000 options.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0277a6df-9147-4ac7-8d60-a73b303fc1e2.pdf) |
| 22 Apr - Board appointed Amit Jain and Abhiroop Jayanthi as additional directors; revised ESOP 2026 pool to 1,30,98,000 options. | [Announcement under Regulation 30 (LODR)-Change in Management 22 Apr - Board appointed Amit Jain and Abhiroop Jayanthi as additional directors; revised ESOP 2026 pool to 1,30,98,000 options.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d5885102-99db-4e0f-a41e-d291d4315402.pdf) |
| 20 Apr - Company changed website to www.viyash.com and investor email to investorrelations@viyash.com. | [Change In Domain Name And Website Of The Company 20 Apr - Company changed website to www.viyash.com and investor email to investorrelations@viyash.com.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/215ecf49-fe82-42f5-9de6-4f10680a1f81.pdf) |
| 15h - Company changed website to www.viyash.com and investor email to investorrelations@viyash.com. | [Change In Domain Name And Website Of The Company 15h - Company changed website to www.viyash.com and investor email to investorrelations@viyash.com.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/215ecf49-fe82-42f5-9de6-4f10680a1f81.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/17cd6a28-1b10-49f6-becb-ec659003ffc6.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/79ef1252-b695-4b03-b5ef-c853705fdca0.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b8423de9-79fe-4ffb-ab9a-482725ba162f.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b9eaa6cb-6902-4077-b056-0edfa34983d4.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/512529/74988512529.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:21:19.950Z.